비정형 항정신병 약물 치료 이후 발생한 비만과 당뇨가 Amisulpride 투여 후 호전된 환자 1예 = A Case Report of a Patient whose Obesity and Diabetes were Induced by Atypical Antipsychotics and Improved by Switching to Amisulpride

다국어 초록 (Multilingual Abstract)

Newer atypical antipsychotics have many benefits compared with conventional antipsychotics. However it has been known that atypical antipsychotics are associated with drug-induced weight gain and dibetes mellitus.
Obesity and diabetes mellitus may be problematic side effects to patients with schizophrenia because they can cause many medical problems and also drug compliance which is important to prognosis can be reduced by those adverse effects.
We present here a male patient, aged 26 year-old, who was treated with risperidone, olanzapine, quetiapine subsequently and gained weight by 32 kilograms (almost 50% increase) during four year-long treatment and diagnosed as having diabetes mellitus.
We switched the antipsychotics to amisulpride at the day of admission and increased the dosage to 800mg. At discharge after 34 days after admission, His psychotic symptoms were considerably improved and blood glucose level at fasting time was stabilized within acceptable range. And he also lost weight by 5 kilograms after admission. Amisulpride would be a relatively appropriate choice of drug in patient with atypical antipsychotics induced weight gain and/or diabetes mellitus.

참고문헌 (Reference)

1 "Weight gain associated with clozapine" 147 : 503-504, 1990

2 "Severe hyperglycemia asociated with high doses of clozapine(leter)" 151 : 1395-, 1994

3 "Risperi-done-asociated diabetes mellitus:a pharmacovigilance study" 23 : 735-744, 2003

4 "Prevalence and corelates of diabetes in national schizophrenia samples" 26 : 903-912, 2000

5 "Peripheral glu-cose metabolism in human hyperprolactinaemia" 43 : 721-726, 1987

6 "Novel antipsychotics and new onset diabetes" 44 : 778-783, 1998

7 "New-onset diabetes mellitus associated with the initiation of quetiapine treatment" 60 : 556-557, 2000

8 "Neurochemical characteristics of amisulpride an atypical dopamine D2/D3 receptor antagonist with both presy-항정신병 약물 유발성 당뇨에서" 15 (15): 236 -240, 2004

9 "Major stresful life events in relation to prevalence of undetected type 2 diabetes:the Hoorn Study" 23 : 197-201, 2000

10 "Long term safety and efficacy of amisulpride in subchronic or chronic schizophre-nia" 15 : 13-2, 2000

11 "Ketoacidosis as a side-efect of clozapine:a case report" 93 : 217-218, 1996

12 Danion JM, "Improvement of schizophrenia patients with primary negative symptoms treated with amisulpride" 156 : 610-616, 1999

13 "Improvement of acute exacerbations of schizophrenia with amisulpride:a comparison with haloperidol" 132 : 396-401, 1997

14 "Impro-vement of some schizophrenic deficit symptoms with low dose amisulpride" 152 : 130-133, 1995

15 "Hyperglycemia asociated with olanzapine" 59 : 687-689, 1998

16 "Hyperglycemia and olanzapine(leter)" 156 : 970-, 1999

17 "Hyperglycemia and antipsychotic medications" 62 : 15-26, 2001

18 "Hormonal evaluation in schi-zophrenic patients treated with neuroleptics" 20 : 199-204, 1999

19 "Dopamine receptor antagonists modulate glucose uptake in rat pheochromocytoma(PC12) cell" 274 : 151-154, 19

20 "Diabetic ketoacidosis asocia-ted with clozapine treatment(letter)" 151 : 1520-1521, 1994

21 "Diabetes mellitus in schizophrenic patients" 37 : 68-73, 1996

22 "Antipsychotic-induced weight gain:a compre-hensive research synthesis" 156 : 1686-1696, 1999

23 Bech P, "Amisulpride versus risperidone in the treatment of acute schizophrenia" Nice, France 23-26, 1997

24 "Amisulpride versus amineptine and placebo for the treatment of dysthymia" 39 : 25-32, 1999

25 Moller J, "Amisulpride in the treatment of subchronic or chronic schizophrenia with acute exacerbation:a double-blind comparison with haloperidol" 132 : 396-401, 1997

26 Loo H, "Amisul-pride versus placebo in the medium-term treatment of the negative symptoms of schizophrenia" 170 : 18-2, 1997

27 "Ami-sulpride vs risperidone in the treatment of acute exacerbations of schizophrenia" 88 : 107-117, 1999

28 Stephen Martin, "A double-blind, randomised comparative trial of amisulpride versus olanzapine tn the treatment of schizophrenia short-term results at two months" 18 (18): 355-362, 2002